Loading...
 
Toggle Health Problems and D

The effect of vitamin D on different human cells, with emphasis on burns and ICU – April 2018

Vitamin D status and its influence on outcomes following major burn injury and critical illness

Burns & Trauma 20186:11, https://doi.org/10.1186/s41038-018-0113-4, 16 April 2018
Khaled Al-Tarrah, Martin Hewison, Naiem Moiemen† and Janet M. Lord† † = Contributed equally

 Download the PDF from VitaminDWiki

Image

Vitamin D deficiency is common among the general population. It is also observed in up to 76% of critically ill patients. Despite the high prevalence of hypovitaminosis D in critical illness, vitamin D is often overlooked by medical staff as the clinical implications and consequences of vitamin D deficiency in acute contexts remain to be fully understood. Vitamin D has a broad range of pleotropic effects on various processes and systems including the immune-inflammatory response. 1α,25-dihydroxyvitamin D (1,25(OH)2D), has been shown to promote a tolerogenic immune response limiting deleterious inflammatory effects, modulation of the innate immune system, and enhancement of anti-microbial peptides. Vitamin D deficiency is frequently observed in critically ill patients and has been related to extrinsic causes (i.e., limited sunlight exposure), magnitude of injury/illness, or the treatment started by medical doctors including fluid resuscitation. Low levels of vitamin D in critically ill patients have been associated with sepsis, organ failure, and mortality. Despite this, there are subpopulations of critical illness, such as burn patients, where the literature regarding vitamin D status and its influence on outcomes remain insufficient. Thermal injury results in damage to both burned and non-burned tissues, as well as induces an exaggerated and persistent immune-inflammatory and hypermetabolic response. In this review, we propose potential mechanisms in which burn injury affects the vitamin D status and summarizes current literature investigating the influence of vitamin D status on outcomes. In addition, we reviewed the literature and trials investigating vitamin D supplementation in critically ill patients and discuss the therapeutic potential of vitamin D supplementation in burn and critically ill patients. We also highlight current limitations of studies that have investigated vitamin D status and supplementation in critical illness. Thermal injury influences vitamin D status. More studies investigating vitamin D depletion in burn patients and its influence on prognosis, via standardized methodology, are required to reach definitive conclusions and influence clinical practice.

Table 1 Effects of vitamin D on various human cell types and tissues

Adipocytes [105]
Inhibits intracellular fat accumulation
Enhances basallipolysis without cell toxicity
Upregulation of p-oxidation-related genes, lipolytic enzymes, and vitamin D-responsive genes
Increased levels of nicotinamide adenine dinucleotide and sirtulin 1 expression

Cardiomyocytes[106, 107]
Inhibition of cellproliferation without apoptosis
Downregulation of expression of genes associated with cell cycle regulation
Promotes cardiomyotube formation
Induces cardiac differentiation

Hepatocytes[108-110]
Protects against insulin resistance
Downregulates fibrogenic TGF-p signaling
Anti-inflammatory effects by inhibiting monocyte activation and TNF-a and IL-1 expression

Myocytes [111,112]
Modulation of calcium homeostasis and influx
Induces cellular proliferation and differentiation
Protects against insulin resistance
Stimulation of arachidonic acid mobilization

Nephrocytes [113]
Upregulation of cellular metabolic activity, IL-6, and reactive oxygen species
Restoration of transepithelial barrier function

Neurons  [114, 115]
Neuroactive steroid modulating spontaneous regular firing, actin potential duration, and intrinsic excitability
Enhances sensitivity to neurotransmitters and neurotransmitter receptors
Upregulation of neuronal growth factors, neurotrophin 3, and glial cell line-derived neurotrophic factor

T cells[17, 116]
Inhibits Th1/Th17 chemokine/ cytokine secretion (CXCL-10, IFN-γ, TNF-α, and IL-17)
Enhances Th2 cytokine release (IL-4 and IL-5)

B cells [117]
Downregulates the proliferation of memory B cells
Inhibits plasma cell differentiation
Reduces Ig production

Antigenpresenting cells[122]
Inhibits the expression of class II MHC molecules (HLA-DR)
Inhibition of co-stimulating molecule expression (CD80, CD83, and CD86)
Augments chemotaxis and phagocytosis of monocytes
Downregulates the maturation of dendritic cells
Induces tolerogenic dendritic cells capable of inducing Treg cells
Inhibits IL-12 p70 release
Decreases macrophagestimulated pro-inflammatory cytokine production (IL-1, IL-1β, IL-6, IL-8, MCP-1, and RANTES)

NK cells[122]
Inhibition of NK cell development and differentiation
Reduced INF-γ and cytotoxicity


Created by admin. Last Modification: Tuesday December 17, 2019 17:45:33 GMT-0000 by admin. (Version 7)

Attached files

ID Name Comment Uploaded Size Downloads
9744 major burn injury and critical illness.pdf admin 21 Apr, 2018 1.23 Mb 850
9743 icu.jpg admin 21 Apr, 2018 145.97 Kb 707